Ouvrir la Science - Publication of an interministerial report on the importance of communicating the results of clinical trials in France

"In the framework of the National Plan for Open Science, the French Ministry of Health and the Ministry of Research set up a working group to develop proposals on how to enhance the transparency of clinical trials, particularly as regards communicating the results of all clinical trials in France. The report by this working group has been approved by the Steering Committee for Open Science, the governance body for Open Science in France.

The transparency of clinical trial results is a core issue for trust and confidence in biomedical research, the quality of patient care and the relevance of public health decisions. In this context, Regulation (EU) No 536/2014 on clinical trials on medicinal products for human use came into force in 2022 and established a harmonised legal framework at the European level to help reinforce transparency throughout the life cycle of clinical trials...."